• KOLs
  • Heart Failure
  • From The Mellen Center For Multiple Sclerosis, Neu

From the Mellen Center for Multiple Sclerosis, Neu: Influence Statistics

From the Mellen Center for: Expert Impact

Concepts for which From the Mellen Center for has direct influence: Heart failure , United states , Prostate cancer , Multiple sclerosis , Atrial fibrillation .

From the Mellen Center for: KOL impact

Concepts related to the work of other authors for which for which From the Mellen Center for has influence: Heart failure , Multiple sclerosis , Prostate cancer , Atrial fibrillation , Oxidative stress , Gene expression , Myocardial infarction .

KOL Resume for From the Mellen Center for Multiple Sclerosis, Neu

Year

Prominent publications by From the Mellen Center for Multiple Sclerosis, Neu

KOL-Index: 31794 . OBJECTIVE: Insertion of tympanostomy tubes is the most common ambulatory surgery performed on children in the United States. Tympanostomy tubes are most often inserted because of persistent middle ear fluid, frequent ear infections, or ear infections that persist after antibiotic therapy. All these conditions are encompassed by the term otitis media (middle ear inflammation). This ...
Known for Tympanostomy Tubes | Tube Insertion Children | 3 Months | Otitis Media
KOL-Index: 29853 . BACKGROUND: In the ongoing phase 3 CheckMate 214 trial, nivolumab plus ipilimumab showed superior efficacy over sunitinib in patients with previously untreated intermediate-risk or poor-risk advanced renal cell carcinoma, with a manageable safety profile. In this study, we aimed to assess efficacy and safety after extended follow-up to inform the long-term clinical benefit of nivolumab ...
Known for Ipilimumab Sunitinib | 3 Trial | Advanced Renal | Cell Carcinoma
KOL-Index: 28233 . BACKGROUND: Prevention of graft-versus-host disease (GvHD) without malignant relapse is the overall goal of allogeneic haemopoietic cell transplantation (HCT). We aimed to evaluate regimens using either maraviroc, bortezomib, or post-transplantation cyclophosphamide for GvHD prophylaxis compared with controls receiving the combination of tacrolimus and methotrexate using a novel composite ...
Known for Mycophenolate Mofetil | Tacrolimus Methotrexate | Host Disease | 2 Trial
KOL-Index: 27953 . BACKGROUND: Identifying risk factors for inferior outcomes after anterior cruciate ligament reconstruction (ACLR) is important for prognosis and future treatment. HYPOTHESIS: Articular cartilage lesions and meniscus tears/treatment would predict International Knee Documentation Committee (IKDC) score, Knee injury and Osteoarthritis Outcome Score (KOOS) (all 5 subscales), and Marx activity ...
Known for Meniscus Tears | Articular Cartilage | 6 Years | Marx Activity
KOL-Index: 26267 . With each breath we exhale, thousands of molecules are expelled in our breath and each one of us has a 'breathprint' that can tell a lot about his or her state of health. While this may be news to some, it should not be to people in medicine. For one can argue that the field of breath analysis is as old as the field of medicine itself. Hippocrates described fetor oris and fetor ...
Known for Exhaled Breath | Nitric Oxide | Airway Inflammation | Medical Testing
KOL-Index: 26074 . PURPOSE: To compare efficacy and safety of 2 dosing regimens of intravitreal aflibercept injection (IAI) with macular laser photocoagulation for diabetic macular edema (DME). DESIGN: Two similarly designed, randomized, phase 3 trials, VISTA(DME) and VIVID(DME). PARTICIPANTS: Patients (eyes; n=872) with type 1 or 2 diabetes mellitus who had DME with central involvement. METHODS: Eyes ...
Known for Eyes Iai | Vista Vivid | Laser Control | Baseline Week
KOL-Index: 25986 . BACKGROUND: Little is known about the incidence of prosthesis-patient mismatch (PPM) and its impact on outcomes after transcatheter aortic valve replacement (TAVR). OBJECTIVES: The objectives of this study were: 1) to compare the incidence of PPM in the TAVR and surgical aortic valve replacement (SAVR) randomized control trial (RCT) arms of the PARTNER (Placement of AoRTic TraNscathetER ...
Known for Severe Aortic | Ppm Tavr | Savr Patients | Surgical Valve
KOL-Index: 25656 . BACKGROUND: Cardiovascular disease (CVD) is the most frequent cause of death in people with early stages of chronic kidney disease (CKD), for whom the absolute risk of cardiovascular events is similar to people who have existing coronary artery disease. This is an update of a review published in 2009, and includes evidence from 27 new studies (25,068 participants) in addition to the 26 ...
Known for Kidney Disease | 95 Statins | Cardiovascular Events | Ckd Dialysis
KOL-Index: 25488 . BACKGROUND: In the Safety and Efficacy of Nintedanib in Systemic Sclerosis (SENSCIS) trial, nintedanib reduced the rate of decline in forced vital capacity (FVC) in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD). Patients on stable treatment with mycophenolate for at least 6 months before randomisation could participate. The aim of this subgroup analysis ...
Known for Senscis Trial | Nintedanib Patients | Systemic Sclerosis | Decline Fvc
KOL-Index: 25272 . OBJECTIVE: This study was undertaken to evaluate the responsiveness of the Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ) in women with pelvic organ prolapse undergoing surgical and nonsurgical management. STUDY DESIGN: The responsiveness of the prolapse, urinary and colorectal scales of the PFDI and PFIQ were assessed in 2 independent populations: (1) ...
Known for Pfdi Pfiq | Pelvic Floor | Pessary Surgery | Organ Prolapse
KOL-Index: 24760 . BACKGROUND: Lung cancer is usually suspected in individuals who have an abnormal chest radiograph or have symptoms caused by either local or systemic effects of the tumor. The method of diagnosis of lung cancer depends on the type of lung cancer (small cell lung cancer or non-small cell lung cancer [NSCLC]), the size and location of the primary tumor, the presence of metastasis, and the ...
Known for Lung Cancer | Chest Physicians | Peripheral Lesions | Sputum Cytology
KOL-Index: 24636 . BACKGROUND: In the ongoing phase 3, CheckMate 214 trial, nivolumab plus ipilimumab improved overall survival compared with sunitinib in patients with intermediate or poor risk, previously untreated, advanced renal cell carcinoma. We aimed to assess whether health-related quality of life (HRQoL) could be used to further describe the benefit-risk profile of nivolumab plus ipilimumab versus ...
Known for Ipilimumab Sunitinib | Renal Cell | 3 Trial | Intermediate Poor Risk
KOL-Index: 24406 . Calmodulin inhibitors are effective in enhancing cytotoxic effects of doxorubicin (DOX) in DOX-resistant cells, possibly by enhancing cellular levels of drug. In the present study, L1210 mouse leukemia cells adapted to grow in vitro, in the presence of 0.025 to 0.25 microgram/ml DOX, and identified as L1210/DOX0.025, L1210/DOX0.05, L1210/DOX0.1, and L1210/DOX0.25 were approximately 5-, ...
Known for Dox L1210 Cells | Resistant L1210 | Presence 5 Microm | Mouse Leukemia
KOL-Index: 24273 . BACKGROUND: Ozanimod is a sphingosine 1-phosphate receptor modulator, which selectively binds to sphingosine 1-phosphate receptor subtypes 1 and 5 with high affinity. In the RADIANCE phase 2 study in participants with relapsing multiple sclerosis, ozanimod was associated with better efficacy than placebo on MRI measures and was well tolerated. The RADIANCE phase 3 study aimed to confirm ...
Known for Multiple Sclerosis | Ozanimod Versus | Phase 3 | Interferon Beta1a
KOL-Index: 24254 . Importance: Transcatheter aortic valve replacement (TAVR) indications are expanding, leading to an increasing number of patients with bicuspid aortic stenosis undergoing TAVR. Pivotal randomized trials conducted to obtain US Food and Drug Administration approval excluded bicuspid anatomy. Objective: To compare the outcomes of TAVR with a balloon-expandable valve for bicuspid vs tricuspid ...
Known for Aortic Stenosis | Valve Replacement | Patients Bicuspid | 1 Year

Key People For Heart Failure

Top KOLs in the world
#1
John J J V McMurray
heart failure myocardial infarction atrial fibrillation
#2
John George Franklin Cleland
heart failure patients hf atrial fibrillation
#3
Stephan D Anker
heart failure iron deficiency cardiac cachexia
#4
Greegg C Fonarow
heart failure atrial fibrillation united states
#5
Karl B Swedberg
heart failure reduced ejection fraction myocardial infarction
#6
Piotr P Ponikowski
heart failure iron deficiency reduced ejection fraction